Lecturer Himalayan College of Nursing HIV/AIDS – An epidemic
• 1st case in sex workers in Chennai, 1986
• > 5.3 million people infected • 6 High prevalence States: Maharashtra, Karnataka, Tamil Nadu, Andhra Pradesh, Manipur, Nagaland • India- world’s 2nd largest burden of HIV-infected persons. – One of every six new HIV infections – two Indians become HIV-infected every minute • Majority due to sexual transmission followed by IV drug use and Mother-to-child transmission • HIV epidemic is spreading from urban to rural populations Known modes of transmission, 2002 Actions Taken
• After 1986, Government took a series of
measures • Realized that AIDS had epidemic proportion in Africa and was spreading rapidly • Govt of India started pilot screening of high risk population National AIDS Committee
• National AIDS Committee in Year 1986
– To formulate strategy & plan for implementation of prevention & control of HIV/AIDS in the country, – to bring together various ministries, NGOs and private institutions for effective co-ordination in implementing the programme • The committee acts as the highest-level deliberation body – to oversee the performance of the programme – to provide overall policy directions, – to forge multisectoral collaborations. • Created public awareness, introduction of blood screening for transfusion and surveillance activities • NACP -1987 Medium Term Plan for HIV/AIDS Control
• 1989, with WHO support, a medium term plan with US $10
million budget • Implemented in 5 affected states & UTs (Maharashtra, Tamil Nadu, West Bengal, Manipur, and Delhi). • Focus on reinforcement of program management capacities & targeted IEC and Surveillance • Preventive activities like implementation of education and awareness program, blood safety measures, control of hospital infection, condom promotion, strengthening clinical services gained momentum in 1992 The National AIDS Control Project
Key objectives
• To reduce the spread of HIV infection in India
• Strengthen India ’s capacity to respond to
HIV/AIDS on a long term basis. National AIDS Control Program
• Implemented in 32 States/UTs & 3 Municipal
Corporations namely Ahmedabad, Chennai & Mumbai through AIDS Control Societies • The 3 new states (Chattisgarh, Uttaranchal,Jharkhand) establishing their State AIDS Control Societies • Access to highly active antiretroviral drugs • Pharma industry instrumental in providing lower cost, generic, fixed dose combinations for HIV-infected patients Components
• Priority targeted interventions for populations at
high risk • Preventive interventions for the general population • Low Cost care for people living with HIV/AIDS • Institutional strengthening • Inter-sectoral collaboration National AIDS Control Programme Phase I and II • Phase-I (1992 - 1999) was implemented across the country with objective to slow the spread of HIV to reduce future morbidity, mortality, and the impact of AIDS by initiating a major effort in the prevention of HIV transmission.
• Phase-II (1999 - 2006) was aimed at reducing spread
of HIV infection in India and strengthen India's capacity to respond to HIV epidemic on long term basis
Dr. KANUPRIYA CHATURVEDI
Significant Achievements of NACP-I &II • Scaling up the high prevalence states. • Increasing access to free ARV is one of the major achievements of NACP-II. • Recognizing the need of care and support for people living with HIV and AIDS and scaling up of Community Care Centers.
Dr. KANUPRIYA CHATURVEDI
Contd. • The effectiveness of the condoms as one of the safest methods to prevent and control the spread of HIV and other STIs has been well established. • Initiating the process for developing draft legislation on HIV and AIDS. • Focus has shifted from raising awareness to behavior change, from a national response to a decentralized response and an increasing engagement of NGOs and networks of people living with HIV/AIDS. • The National AIDS Prevention and Control Policy and the National Council on AIDS (NCA), chaired by the Prime Minister, provide policy guidelines and political leadership to the response. Phase-III (2007-2012) • Phase-III (2007-2012)is based on the experiences and lessons drawn from NACP-I and II, and is built upon their strengths. Its priorities and thrust areas are drawn up accordingly and include the following: – Considering that more than 99 percent of the population in the country is free from infection, NACP-III places the highest priority on preventive efforts while, at the same time, seeks to integrate prevention with care, support and treatment. Contd. – Sub-populations that have the highest risk of exposure to HIV receive the highest priority in the intervention programs. These would include sex workers, men- who-have-sex-with-men and injecting drug users. Second high priority in the intervention programs is accorded to long-distance truckers, prisoners, migrants (including refugees) and street children. – In the general population those who have the greater need for accessing prevention services, such as treatment of STDs, voluntary counseling and testing and condoms, will be next in the line of priority. Contd. – NACP-III ensures that all persons who need treatment would have access to prophylaxis and management of opportunistic infections. People who need access to ART will also be assured first line ARV drugs. – Prevention needs of children are addressed through universal services. Children who are infected are assured access to pediatric ART. – NACP-III is committed to address the needs of persons infected and affected by HIV, especially children. Contd. • NACP-III also plans to invest in community care centres to provide psycho-social support, outreach services, referrals and palliative care. • Socio-economic determinants that make a person vulnerable also increase the risk of exposure to HIV. NACP-III will work with other agencies involved in vulnerability reduction such as women's groups, youth groups, trade unions etc. to integrate HIV prevention into their activities Policy on Antiretroviral therapy
• Efforts to exempt customs duty on drugs to reduce cost
• The ART is not provided under National Program • However, in training for doctors rationale use of ART emphasized. • ART drugs provided in cases of post-exposure prophylaxis to health care providers and the feasibility study project on prevention of mother to child transmission. Initiative • The WHO declared lack of access to ART as a ‘global health emergency’ in September 2003 • Joint WHO/UNAIDS emergency plan to scale up access to treatment for at least 3 million by 2005. • Government of India has issued guidelines for phased scale up of access to antiretroviral therapy for people living with HIV/AIDS. Initiatives in India • 1 million people in 6 high prevalent states will receive antiretroviral (ARV) drugs free of cost from 1 st April 2004 targeted to 3 vulnerable groups – mothers who participated in the Prevention of Parent to Child Transmission (PPTCT) program as seropositive antenatal cases – seropositive children below the age of 15 years – people with AIDS who seek treatment in selected government hospitals • Govt of India in dialogue with pharma to optimize additional potential reduction in cost of ARV drugs State Level Srengthening
• Strengthen program management at state level
• Established organizations as per the guidelines of the strategic plan – State AIDS control societies (State AIDS cells), – Technical advisory committees – Empowered committees State AIDS Control Societies • takes the policy decisions for implementation of the HIV/AIDS control program • administrative and financial actions Recent Initiatives • In Dec 1998, Prime Minister, Mr Atal Bihari Vajpayee acknowledged that HIV/AIDS was a serious public health problem • In July 2003, the Prime Minister gave call to elected representatives to display political courage to address HIV/AIDS issues • Momentum in political advocacy continued strongly • Parliamentary forum of elected representatives (Members of Parliament) was established for HIV/AIDS research that comprised members from all major political parties contd
• Feasibility study to reduce mother-to-child transmission
initiated by NACO in Mar 2000 in 11 maternity hospitals with little experience in HIV/AIDS research • Decision to scale up services to reduce mother-to-child transmission in six Indian states • Rapid change from non - recognition to acceptance as a public health problem • Decision to provide free ART to persons having advanced HIV disease was taken Course of Events
• International AIDS Vaccine Initiative (IAVI) undertook an
effective campaign for HIV vaccine trials • The President of India, Mr. Abdul Kalam supported conduct of HIV vaccine trial • In Feb 2005, the first Phase I HIV vaccine trial was initiated in the National AIDS Research Institute (NARI), Pune. • Another HIV vaccine trial using an indigenously developed vaccine is expected to be initiated in Tuberculosis Research Centre, Chennai by the end of 2005. HIV/AIDS Trial • NACO, ICMR entered into a Memorandum of Understanding (MOU) with global, not-for-profit International AIDS Vaccine Initiative (IAVI) in December 2000 • An extensive 2 year exercise was undertaken to prepare the site, design the study and mobilise the volunteer groups before initiating the HIV vaccine trial • Adopted a multiple AIDS vaccine candidate approach Vaccine Trial Preparedness activities in India • Preparedness activities initiated in 2002 & Ph II in Feb 2005 • Effective campaign for political advocacy helped accelerate implementation of HIV prevention & treatment strategies, research responses and its implementation • Strong political support strengthened research efforts in institutions already involved in HIV/AIDS work and also those who were not adequately exposed Involvement of Policy Makers
• Vaccine programme initiated with a Policy Makers
conference in May 2002 – brought together parliamentarians from 8 developing countries to share their perspective • Program received strong support from top political leadership – Prime Minister of India, Leader of Opposition, Hon’ President of India and Chief Ministers of high prevalence states. • Effort to keep policy makers engaged with programme – Held policy workshops, one-on-one consultations, regular briefings at national level, specific workshops with state legislators at the regional level Processes • Community Involvement • Formative Community Research • Study to see willingness to participate for the Phase I Vaccine Trial • Committee of Parliamentarians • Civil Society Stakeholders Interactions • Media Orientation • National AIDS Vaccine Advisory Board (NAB) Advisory Expert Panels
• Expert panels were set up to address the concerns
and issues that emerged from the consultations with the various stakeholders – National AIDS Vaccine Advisory Board – Informed Consent Group – NGO Working Group – National Consultation on HIV Care and Treatment – Gender Advisory Board Major Achievements
• HIV sentinel surveillance mapping of high risk & vulnerable grps
in over 30 states and UTs • National Blood Policy, 2002 & Action Plan on Blood Safety, 2003. – Action Plan has mandated revelation of HIV status to result seeking donor, & brought in accreditation of blood banks • Care & support and introduced ART • Mobilized grants for managing the opportunistic infections and extending antiretroviral treatment for AIDS. • Awareness generation, expanding services for people with AIDS • Creating new partnerships • Initiation of the HIV/AIDs Vaccine trial Thank you